Two chemicals found in anti-fertility folk medicines block a key step in fertilization – the meeting of egg and sperm – and may make effective alternatives to today’s hormone-based contraceptives, which sometimes cause side effects.
The chemicals are effective at low doses that seem to have no adverse effect on egg or sperm, other than to prevent the sperm from pushing through the cells that congregate around the egg and an enveloping membrane called the zona pelucida.
They work by stopping sperm’s power kick, which is normally stimulated by the hormone progesterone secreted by cells surrounding the egg and makes the sperm’s tail whip forcefully to propel it toward and into the egg.
The chemicals could serve as an emergency contraceptive taken either before or after intercourse, or as a permanent contraceptive via a skin patch or vaginal ring, say researchers at the University of California, Berkeley. Human sperm take about five to six hours to mature once they enter the female reproductive system, which is enough time for the drug to enter the system and block the kick.
Also, because the chemicals prevent fertilization, they may be a more acceptable alternative in the eyes of those who object to emergency contraceptives, such as Plan B, that prevent the implantation of a potentially viable fertilized egg.
“Because these two plant compounds block fertilization at very, very low concentrations – about 10 times lower than levels of levonorgestrel in Plan B – they could be a new generation of emergency contraceptive we nicknamed ‘molecular condoms,’” said Polina Lishko, an assistant professor of molecular and cell biology, who led the team that discovered the anti-fertility properties of the two chemicals. “If one can use a plant-derived, non-toxic, non-hormonal compound in lesser concentration to prevent fertilization in the first place, it could potentially be a better option.”
Lishko, first author Nadja Mannowetz, a project scientist, and former postdoctoral fellow Melissa Miller will report their findings online this week in the journal Proceedings of the National Academy of Sciences.
Sperm’s power kick
Lishko and her lab colleagues study male and female reproduction, including the hormones that trigger hyperactivity in sperm. Sperm swim upstream in the reproductive track toward the egg using their tail, which normally moves with a steady, rhythmic motion. However, once sperm reach the egg and its protective cluster of cells, their tails switch to a whiplike motion, a power kick that gets the sperm through the scrum and into the egg. The key to this power kick is a calcium channel, called CatSper; when opened, calcium floods the tail, triggering the forceful tail snaps.
Last year, the three researchers found that the hormone progesterone is key to opening the calcium channel and triggering tail whipping. The hormone binds to a protein called ABHD2, which in turn opens the channel. They began a search for other chemicals that would bind to ABHD2, either opening the channel, like progesterone, or blocking the channel.“The massive influx of calcium into the sperm tail changes the sperm tail’s beating pattern, making it highly asymmetrical,” Mannowetz said. “This asymmetrical bending gives the sperm cell enough force to drill through the tenacious egg vestment.”
In the new study, Mannowetz tested three other hormones: testosterone, estrogen and cortisol, a stress hormone. All three competed with progesterone and blocked tail whipping, though only testosterone and cortisol were effective at levels typical of the hormones’ levels in the body. This suggests, she said, that stress and high testosterone levels in women decrease fertility in part by preventing sperm from penetrating the egg.
They also found a second hormone that triggers tail whipping: a steroid structurally similar to progesterone called pregnenolone sulfate.
Purusing books on natural contraceptives used by indigenous peoples around the world, they came across several non-steroid chemicals isolated from anti-fertility plants that resembled the steroids that bind to ABHD2 and block CatSper. One of these was pristimerin, from the plant Tripterygium wilfordii, also known as “thunder god vine,” and another Paraguayan antifertility herb, Maytenus ilicifolia, referred to as Espinheira Santa. Leaves from the thunder god vine have been used as an antifertility drug in Chinese traditional medicine, though some compounds in the leaves are poisonous. It has also been used as a folk remedy for rheumatoid arthritis.
The other chemical was lupeol, which is found in plants such as mango and dandelion root. While it has been tested as an anticancer agent, it was not suspected of having contraceptive properties.
Mannowetz found that both pristimerin and lupeol blocked progesterone binding to ADHD2, preventing sperm’s power kick.
“These compounds not only blocked calcium channel activation, but also blocked sperm hyperactivated motility, reducing their activity to the level of nonactivated sperm cells,” Lishko said. “It doesn’t kill sperm basal motility. It is not toxic to sperm cells; they still can move. But they cannot develop this powerful stroke, because this whole activation pathway is shut down.”
Lishko and her colleagues are now working with researchers in Oregon to test how effective these chemicals are in preventing primate in vitro fertilization, since their own studies involved human sperm only. They also are searching for an inexpensive source of the chemicals, members of a family called triterpenoids, since concentrations in wild plants are too low for cost-effective extraction.
The Latest on: Contraceptives
- Celmatix Biosciences Launches Search for Next-Generation Oral Contraceptives on December 19, 2018 at 6:42 am
Program Will Investigate the Capability of Genomic Insights to Identify Novel Contraceptive Drug Targets for Women with Support from the Bill & Melinda Gates Foundation NEW YORK, Dec. 19, 2018 /PRNews... […]
- It’s getting easier to get FDA approval — just ask Natural Cycles on December 19, 2018 at 5:50 am
While this clearance may appear to increase the number of effective birth control methods available to patients, it has not been tested with nearly the same rigor as other FDA-approved contraceptives ... […]
- Industry’s tone deaf response to the ‘Implant Files’ exposé on December 19, 2018 at 4:37 am
contraceptives and other medical implants that injured patients and sometimes contributed to their death. “In the U.S., the Food and Drug Administration (FDA) has collected 5.4 million ‘adverse event’ ... […]
- Contraceptives Market to Witness Robust Expansion Throughout the Forecast 2015 - 2025 on December 18, 2018 at 3:44 am
Valley Cottage, NY -- (SBWIRE) -- 12/18/2018 -- Contraception is deliberate prevention of pregnancy by interfering with normal process of ovulation, fertilization and implantation through the use of b... […]
- Contraceptives Market Is Expected To Accomplish A Valuation Of Around USD 30.86 Million By 2022: Grand View Research, Inc. on December 17, 2018 at 9:32 am
According to report published by Grand View Research,Global contraceptives market is expected to reach USD 30.86 million by 2022. Growing prevalence of sexually transmitted infections (STIs), especial... […]
via Google News and Bing News